(19)

(11)

EP 4 196 151 A1

(12)

(43) Date of publication: 21.06.2023 Bulletin 2023/25 (21) Application number: 21778257.2 (22) Date of filing: 13.08.2021

(51) International Patent Classification (IPC):  A61K 39/00(2006.01) C07K 14/725(2006.01) A61K 31/519(2006.01) A61K 31/454(2006.01) A61P 35/00(2006.01) C07K 14/705(2006.01) A61K 45/06(2006.01) (52) Cooperative Patent Classification (CPC): A61K 39/0012; A61K 2039/892; A61P 35/00; C07K 14/7051; C07K 14/705; C07K 2319/03; A61K 39/001102; A61K 45/06; A61K 31/454; A61K 31/502; A61K 31/5025; A61K 31/4184; A61K 31/55   C-Sets: A61K 31/5025, A61K 2300/00; A61K 31/4184, A61K 2300/00; A61K 31/55, A61K 2300/00; A61K 39/001102, A61K 2300/00; A61K 39/0012, A61K 2300/00; A61K 31/454, A61K 2300/00; A61K 31/502, A61K 2300/00; (86) International application number: PCT/US2021/046041 (87) International publication number: WO 2022/036285 (17.02.2022 Gazette 2022/07)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 14.08.2020 US 202063066150 P 02.10.2020 US 202063087049 P 28.07.2021 US 202163226712 P (71) Applicants: Cero Therapeutics, Inc. South San Francisco, CA 94080 (US) Corey, Daniel Mark Menlo Park, CA 94025 (US) Kipniss, Nathan South San Francisco, California 94080 (US) O'Donoghue, Geoff South San Francisco, California 94080 (US)

(72) Inventors: COREY, Daniel Mark Menlo Park, California 94025 (US) KIPNISS, Nathan San Francisco, California 94080 (US) O'DONOGHUE, Geoff San Francisco, California 94080 (US) (74) Representative: Hoffmann Eitle  Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)